112 related articles for article (PubMed ID: 9312815)
21. [Managing side effects. Individualized dosage makes indinavir more tolerable].
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():84. PubMed ID: 15011605
[No Abstract] [Full Text] [Related]
22. Twice-a-day Crixivan study discontinued.
Newsline People AIDS Coalit N Y; 1998; ():31. PubMed ID: 11367502
[TBL] [Abstract][Full Text] [Related]
23. AmFAR extols FDA on rapid approval of two protease inhibitors.
AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
[No Abstract] [Full Text] [Related]
24. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
[TBL] [Abstract][Full Text] [Related]
25. Indinavir (Crixivan): new packaging and strength.
Res Initiat Treat Action; 1999 Apr; 5(2):33. PubMed ID: 11366284
[TBL] [Abstract][Full Text] [Related]
26. Ritonavir and indinavir one year later.
TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
[No Abstract] [Full Text] [Related]
27. Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study).
Florence E; Dreezen C; Desmet P; Smets E; Fransen K; Vandercam B; Pelgrom J; Clumeck N; Colebunder R
Antivir Ther; 2001 Dec; 6(4):255-62. PubMed ID: 11878407
[TBL] [Abstract][Full Text] [Related]
28. [A plea for an individualized therapy regimen. Which is the optimal dose?].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():26-7. PubMed ID: 12043067
[No Abstract] [Full Text] [Related]
29. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
[No Abstract] [Full Text] [Related]
30. [Antiretroviral therapy in HIV infection. Effects of the introduction of new drugs on health care expenditures, 1994-1999].
Manfredi R; Fiacchi P; Riolo U; Chiodo F
Recenti Prog Med; 2000 Sep; 91(9):425-9. PubMed ID: 11021163
[TBL] [Abstract][Full Text] [Related]
31. Treatment of AIDS.
Kharkar RD
J Indian Med Assoc; 2002 Mar; 100(3):203. PubMed ID: 12408288
[No Abstract] [Full Text] [Related]
32. Combination study of Invirase and Norvir starting.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
[No Abstract] [Full Text] [Related]
33. Saquinavir plus ddC reduces deaths by more than two-thirds.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363697
[TBL] [Abstract][Full Text] [Related]
34. Protease inhibitors shine in triple combinations.
AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
[TBL] [Abstract][Full Text] [Related]
35. [Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].
Mouroux M; Bossi P; Yvon-Groussin A; Delaugerre C; Valantin MA; Tubiana R; Coutellier A; Bonmarchand M; Bricaire F; Katlama C; Agut H; Huraux JM; Calvez V
Pathol Biol (Paris); 1999 May; 47(5):549-52. PubMed ID: 10418038
[TBL] [Abstract][Full Text] [Related]
36. Targeting a deadly scrap of genetic code.
Cowley G
Newsweek; 1996 Dec; 128(23):68-9. PubMed ID: 10162944
[No Abstract] [Full Text] [Related]
37. [Clinical application of HIV protease inhibitors].
Chiba N; Shintani M; Ueno T; Hayashi H
Tanpakushitsu Kakusan Koso; 1998 May; 43(6):744-51. PubMed ID: 9612068
[No Abstract] [Full Text] [Related]
38. Role of viral load blips, drug boosting, and therapeutic holidays in HIV patient management.
Bean P
Am Clin Lab; 2001 Sep; 20(8):11-3. PubMed ID: 11586932
[No Abstract] [Full Text] [Related]
39. Protease inhibitors and prevention of cross resistance.
Levin J
AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
[TBL] [Abstract][Full Text] [Related]
40. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
